Hadean Ventures
Venture capitalSeries A–Series C · 20 people tracked
Investment thesis
Hadean Ventures invests in science-driven solutions addressing complex, real-world healthcare challenges and unmet needs across multiple sectors and investment stages. The firm seeks to generate strong financial returns while creating meaningful impact in the future of healthcare and life sciences innovation.
Source: firm website, verified Jul 21, 2026.
Team · 20 people
from the firm's websiteInvestments · 21 tracked
founders shown can be your intro pathSwedish drug development company focused on treatments for rare primary mitochondrial diseases.
Radiopharmaceutical company developing targeted cancer therapies using alpha-particle emitting radionuclides.
Digital therapeutics company based in Stockholm developing AI-powered mental health treatments.
Spanish biopharmaceutical company developing advanced RNA treatments for rare genetic diseases.
Pharmaceutical company based in Stockholm developing treatments for acute life-threatening conditions including pulmonary hypertension.
Norwegian company developing innovative technology to repair the mitral valve via a transcatheter approach.
Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
German-headquartered biotechnology company developing complement pathway inhibitors for geographic atrophy and other conditions.
San Diego-based company focused on developing therapeutics for neurological and inflammatory diseases.
European biopharmaceutical company advancing a nectin-4 antibody-drug conjugate for solid tumour oncology.
Danish drug development company based in Copenhagen focusing on galectin biology for fibrosis and oncology.
Privately held Swedish company developing novel mPGES-1 inhibitors with anti-inflammatory and pain-relieving properties for endometriosis.
Digital health company based in Tampere, Finland developing the AI-powered Nelli® seizure monitoring system.
Medical device company from Trondheim, Norway developing advanced ultrasound technology for neurological conditions.
Drug development company based in Oslo developing Radspherin®, a radiopharmaceutical for peritoneal metastases.
Company developing a platform technology to synthesise long, complex DNA molecules for gene therapy and synthetic biology applications.
Medical diagnostics company based in Lund, Sweden offering the Pathlight™ MRD test for ultrasensitive cancer liquid biopsies.
German biotechnology company developing iRhom2 inhibitors for inflammatory and autoimmune diseases.
Company developing novel therapeutics that inhibit the enzyme CTPS1 for T-cell malignancies and solid tumours.
Private biotechnology company developing TGD001 for targeted protein degradation in oncology.
Vaccine development company based in Vienna.
Frequently asked questions
- What stage does Hadean Ventures invest at?
- Hadean Ventures invests at the Series A, Series B, Series C stages.
- What sectors does Hadean Ventures focus on?
- Hadean Ventures focuses on Biotech, Healthtech, Medical Devices.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.